Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Neoadjuvant Therapy × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Neoplasms 6 Esophageal Squamous Cell Carcinoma 5 Rectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Surgery 1 Stomach Neoplasms 1 Stage III and IV Ovarian Cancer 1 Squamous Cell Carcinoma of External Auditory Canal 1 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡